Skip to main content

Glide XP fragment docking and structurebased pharmacophores

In recent years, fragment-based drug design has become increasingly popular. Common computational approaches include building fragments up sequentially, or linking disparate fragments. However, the former approach can restrict the exploration of chemical space and may produce ligands that are not sufficiently drug-like, whereas the latter approach may result in difficulties when linking together the individual fragments.

Here, we describe a third approach that avoids these problems with the use of fragment-derived pharmacophore hypotheses. In our computational workflow a pharmacophore hypothesis is created using fragments docked and ranked by Glide XP, and virtual databases are screened against this hypothesis using Phase [1]. In an initial validation study on P38 Map Kinase, known active compounds were successfully retrieved and good enrichment factors were obtained.

References

  1. 1.

    Dixon SL: J Comput Aided Mol Des. 2006, 20: 647-671. 10.1007/s10822-006-9087-6.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to W Sherman.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Sherman, W., Friesner, R. Glide XP fragment docking and structurebased pharmacophores. Chemistry Central Journal 3, P45 (2009). https://doi.org/10.1186/1752-153X-3-S1-P45

Download citation

Keywords

  • Validation Study
  • Enrichment Factor
  • Dock
  • Computational Approach
  • Drug Design